NDC properties for "adalimumab-ryvk 20 MG per 0.2 ML Prefilled Syringe" (RxCUI 2688819)
About this data
The tables show NDC propoerties for adalimumab-ryvk 20 MG per 0.2 ML Prefilled Syringe with the RxCUI 2688819
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-ryvk 20 MG per 0.2 ML Prefilled Syringe (RxCUI 2688819)
| BLA | BLA761299 |
|---|---|
| RxCUI | 2688819 |
| SPL_SET_ID | 2d19a877-1f5a-4731-800a-dddadc424080 |
| VUID | 4043717 |
| VUID | 4043718 |
| Prescribable Synonym | adalimumab-ryvk 20 MG in 0.2 ML Prefilled Syringe |
| RXNAV_STR | 0.2 ML adalimumab-ryvk 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.2 ML adalimumab-ryvk 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | adalimumab-ryvk 20 MG per 0.2 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2688819) |
NDC Properties
NDC Item 51759036222
| NDC 9 | 51759-362 |
|---|---|
| NDC 10 | 51759-362-22 |
| NDC Item | 51759036222 |
| Packaging | 2 KIT in 1 CARTON (51759-362-22) / 1 KIT in 1 KIT * .4 mL in 1 POUCH (65517-0002-1) * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE (51759-497-31) |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-362 |